OncoMed Pharmaceuticals Inc Business Operations Contracts & Agreements
19 Contracts & Agreements
- Collaboration Agreements (13 contracts)
- Indemnification Agreements (1)
- Management Agreements (3)
- MOUs (1)
- Sales Agreements (1)
- Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and Invesco Asset Management Limited, as agent for and on behalf of its discretionary managed client,... (Filed With SEC on December 6, 2018)
- Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and Invesco Asset Management Limited, as agent for and on behalf of its discretionary managed client,... (Filed With SEC on December 6, 2018)
- Shareholder Support Agreement, by and between OncoMed Pharmaceuticals, Inc. and Invesco Asset Management Limited, as agent for and on behalf of its discretionary managed client,... (Filed With SEC on December 6, 2018)
- Amendment 6 to the Collaboration and Option Agreement, dated June 13, 2018, by and between the registrant and Bayer Pharma AG (Filed With SEC on August 2, 2018)
- AMENDMENT 5 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on March 9, 2017)
- AMENDMENT 4 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on November 1, 2016)
- AMENDMENT 3 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on March 10, 2016)
- AMENDMENT NO. 1 to the Multi-Product LicenseAgreement dated 22 August 2012 between LONZA SALES AG and ONCOMED PHARMACEUTICALS, INC 1 (Filed With SEC on March 12, 2015)
- AMENDMENT 2 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on November 13, 2013)
- COLLABORATION AGREEMENT between LONZASALES AG and ONCOMED PHARMACEUTICALS, INC. (Filed With SEC on October 25, 2012)
- AMENDMENT 1 TO THE COLLABORATION AND OPTION AGREEMENT (Filed With SEC on October 25, 2012)
- COLLABORATION AND OPTION AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND BAYER SCHERING PHARMA AG DATED JUNE 15, 2010 TABLE OF CONTENTS (Filed With SEC on July 5, 2012)
- AMENDMENT NO. 1 TO THE RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT (Filed With SEC on July 5, 2012)
- RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND SMITHKLINE BEECHAM CORPORATION DECEMBER 7, 2007 TABLE OF... (Filed With SEC on July 5, 2012)
- ONCOMED PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on July 3, 2012)
- MEMORANDUM OF UNDERSTANDING (Filed With SEC on May 11, 2012)
- COLLABORATION AND OPTION AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND BAYER SCHERING PHARMA AG DATED JUNE 15, 2010 TABLE OF CONTENTS (Filed With SEC on May 11, 2012)
- AMENDMENT NO. 1 TO THE RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT (Filed With SEC on May 11, 2012)
- RESEARCH AND DEVELOPMENT COLLABORATION, OPTION, AND LICENSE AGREEMENT BY AND BETWEEN ONCOMED PHARMACEUTICALS, INC. AND SMITHKLINE BEECHAM CORPORATION DECEMBER 7, 2007 TABLE OF... (Filed With SEC on May 11, 2012)
